Price T Rowe Associates Inc. MD Has $182,000 Holdings in The Beauty Health Company (NASDAQ:SKIN)

Price T Rowe Associates Inc. MD increased its stake in The Beauty Health Company (NASDAQ:SKIN) by 19.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 114,147 shares of the company’s stock after purchasing an additional 18,400 shares during the period. Price T Rowe Associates Inc. MD owned approximately 0.09% of Beauty Health worth $182,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SKIN. SG Americas Securities LLC boosted its stake in shares of Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company’s stock worth $56,000 after buying an additional 9,749 shares during the last quarter. Barclays PLC boosted its stake in shares of Beauty Health by 11.1% during the 4th quarter. Barclays PLC now owns 117,920 shares of the company’s stock worth $187,000 after buying an additional 11,817 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Beauty Health in the 4th quarter valued at about $25,000. Newman Dignan & Sheerar Inc. raised its holdings in shares of Beauty Health by 39.1% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 71,144 shares of the company’s stock valued at $113,000 after purchasing an additional 20,000 shares during the period. Finally, Bank of Montreal Can raised its holdings in shares of Beauty Health by 32.6% in the 4th quarter. Bank of Montreal Can now owns 113,096 shares of the company’s stock valued at $180,000 after purchasing an additional 27,791 shares during the period. 93.26% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Canaccord Genuity Group dropped their target price on shares of Beauty Health from $1.50 to $1.25 and set a “hold” rating on the stock in a report on Monday, May 5th.

Beauty Health Stock Up 0.6%

Shares of SKIN stock opened at $1.74 on Friday. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. The firm’s 50-day moving average is $1.21 and its 200-day moving average is $1.45. The stock has a market cap of $217.93 million, a price-to-earnings ratio of -4.14 and a beta of 0.88. The Beauty Health Company has a 52-week low of $0.78 and a 52-week high of $2.76.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, May 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.05. The company had revenue of $69.60 million for the quarter, compared to analysts’ expectations of $63.88 million. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. Sell-side analysts predict that The Beauty Health Company will post -0.25 EPS for the current year.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.